Your browser is no longer supported. Please, upgrade your browser.
Settings
GBS [NASD]
GBS Inc.
Index- P/E- EPS (ttm)-0.71 Insider Own46.90% Shs Outstand11.80M Perf Week49.65%
Market Cap50.43M Forward P/E- EPS next Y- Insider Trans0.02% Shs Float6.58M Perf Month24.21%
Income-6.90M PEG- EPS next Q- Inst Own0.50% Short Float1.34% Perf Quarter-38.43%
Sales0.41M P/S124.23 EPS this Y-43.80% Inst Trans15.84% Short Ratio0.28 Perf Half Y-
Book/sh1.35 P/B3.19 EPS next Y- ROA- Target Price- Perf Year-
Cash/sh1.22 P/C3.53 EPS next 5Y- ROE- 52W Range2.44 - 14.24 Perf YTD-41.76%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-69.73% Beta-
Dividend %- Quick Ratio10.60 Sales past 5Y- Gross Margin- 52W Low76.57% ATR0.44
Employees7 Current Ratio10.60 Sales Q/Q- Oper. Margin- RSI (14)63.60 Volatility19.47% 10.47%
OptionableNo Debt/Eq0.00 EPS Q/Q69.70% Profit Margin- Rel Volume34.87 Prev Close3.63
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume318.79K Price4.31
Recom- SMA2040.64% SMA508.34% SMA200-27.13% Volume11,115,499 Change18.73%
Jun-08-21 08:10AM  
03:29AM  
May-14-21 08:30AM  
Apr-15-21 11:29AM  
Mar-23-21 03:36AM  
Feb-18-21 08:53AM  
Feb-16-21 08:00AM  
Dec-28-20 05:13PM  
Dec-23-20 05:12PM  
10:49AM  
Dec-22-20 10:17PM  
GBS Inc. operates as a biosensor diagnostic technology company. Its principal product is Saliva Glucose Biosensor, a saliva glucose monitoring system for diabetes management. The company also focuses on developing other diagnostic tests in the areas of biochemistry, tumor markers, immunology, hormones, and other biomarkers. It has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. GBS Inc. was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was founded in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gavrilenko VictoriaDirectorMar 02Buy8.093729637Mar 03 07:24 PM
TOWERS CHRISTOPHERDirectorFeb 24Buy6.848005,472800Feb 25 07:22 AM